Dianthus Therapeutics (DNTH) Shares Outstanding (2017 - 2025)

Dianthus Therapeutics' Shares Outstanding (Entity) history runs 8 years deep, the most recent figure standing at $32.2 million for Q2 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 9.62% year-over-year to $32.2 million in Q2 2025; TTM through Jun 2025 was $32.2 million, a 9.62% increase from a year earlier, with the FY2024 full-year figure at $31.1 million, up 503.78% from the prior year.
• Shares Outstanding (Entity) steadied at $32.2 million in Q2 2025 per DNTH's latest filing, from $32.1 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $32.2 million in Q2 2025 and bottomed at $3.0 million in Q1 2021.
• The 5-year median for Shares Outstanding (Entity) is $3.8 million (2023), against an average of $12.7 million.
• Across the five-year window, Shares Outstanding (Entity) rose 0.58% in 2022 and jumped 674.31% in 2024, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $3.7 million in 2021, then climbed by 3.13% to $3.8 million in 2022, then soared by 35.97% to $5.2 million in 2023, then soared by 503.78% to $31.1 million in 2024, then grew by 3.41% to $32.2 million in 2025.
• Per Business Quant, the three latest DNTH Shares Outstanding (Entity) figures stand at $32.2 million (Q2 2025), $32.1 million (Q1 2025), and $31.1 million (Q4 2024).